Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised Controlled Trial of sedation for colonoscopy: Entonox versus Midazolam/Fentanyl
ISRCTN ISRCTN81142957
ClinicalTrials.gov identifier
Public title Randomised Controlled Trial of sedation for colonoscopy: Entonox versus Midazolam/Fentanyl
Scientific title
Acronym N/A
Serial number at source N0084160165
Study hypothesis Does nitrous oxide (Entonox) provide better pain relief than the conventional intravenous sedation during colonoscopy
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Surgery: Sedation
Participants - inclusion criteria All patients undergoing elective colonoscopy would be prospective participants.
Participants - exclusion criteria 1. History of chronic respiratory disease
2. History of colonic resection
3. Intolerance to the drugs
4. Patients with pre-existing adbominal or perianal pain
5. Unwilling participants
Anticipated start date 11/03/2005
Anticipated end date 10/02/2006
Status of trial Completed
Patient information material
Target number of participants 100
Interventions Prospective randomised controlled study. Pilot study initially involving 100 patients to determine statistical power.
Pts will be randomised using the sealed envelope method of block randomisation. Patients randomised to the entonox group will be taught methods of use. Patients will be shown the visual analogue score for pain and asked to mark them.
Those randomised to conventional intravenous sedation will be informed of same and will undergo colonoscopy using standard intravenous sedation protocols.
Entonox group encouraged to inhale the nitrous oxide for a full 60 seconds initially and then as and when required throughout procedure. Post colonoscopy both groups will be asked to indicate pain using visual analogue scale in the recovery.
Primary outcome measure(s) Pain score assessed by VAS
Secondary outcome measure(s) Not provided at time of registration
Sources of funding The North and South Bank Research and Development Consortium (UK) - NHS R&D Support Funding
Trial website
Publications 2009 conference proceedings in http://www.ncbi.nlm.nih.gov/pubmed/19283736
Contact name Mr  Graeme  Duthie
  Address Acadmemic Surgical Unit
Hull and East Yorkshire Hospitals (NHS) Trust
Castle Hill Hospital
  City/town Hull
  Zip/Postcode HU16 5JQ
  Country United Kingdom
  Tel +44 (0)1482 623247
  Fax +44 (0)1482 623274
  Email G.S.Duthie@hull.ac.uk
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 25/06/2010
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central